Kentucky Retirement Systems Insurance Trust Fund Acquires 1,956 Shares of Humana Inc. (NYSE:HUM)

Kentucky Retirement Systems Insurance Trust Fund boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 54.9% during the 4th quarter, Holdings Channel reports. The firm owned 5,521 shares of the insurance provider’s stock after buying an additional 1,956 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Humana were worth $1,401,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Pinnacle Wealth Management Advisory Group LLC raised its stake in Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the period. Atlas Brown Inc. raised its stake in Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the period. Moors & Cabot Inc. raised its stake in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the period. Mather Group LLC. raised its stake in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the period. Finally, OLD National Bancorp IN raised its stake in Humana by 1.8% during the 3rd quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock valued at $828,000 after purchasing an additional 45 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

HUM opened at $257.24 on Wednesday. The business has a fifty day moving average of $270.05 and a 200 day moving average of $291.47. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $30.97 billion, a P/E ratio of 22.78, a PEG ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts anticipate that Humana Inc. will post 16.11 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on HUM. Wells Fargo & Company cut their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. JPMorgan Chase & Co. cut their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday. Royal Bank of Canada restated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Truist Financial raised their price target on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, Barclays raised their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $285.68.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.32% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.